AbbVie Reports First-Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Abbvie (ABBV) PT Raised to $101 at Deutsche Bank
April 27, 2018 7:49 AM EDTDeutsche Bank raised its price target on Abbvie (NYSE: ABBV) to $101.00 (from $100.00) while maintaining a Hold rating.
... MoreAbbVie (ABBV) Plans $7.5B Tender Offer
April 26, 2018 7:52 AM EDTWith earnings, AbbVie (NYSE: ABBV) said it plans to commence a tender offer to purchase for cash up to $7.5 billion in value of shares of its common stock through a modified "Dutch auction" tender offer at a specified price range to be determined.... More
AbbVie (ABBV) Tops Q1 EPS by 8c, Raises FY EPS Guidance
April 26, 2018 7:48 AM EDTAbbVie (NYSE: ABBV) reported Q1 EPS of $1.87, $0.08 better than the analyst estimate of $1.79. Revenue for the quarter came in at $7.93 billion versus the consensus estimate of $7.6 billion.
GUIDANCE:
AbbVie sees FY2018 EPS of $7.66-$7.76, versus the consensus of... More
